We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Proteomic non-small cell lung carcinoma biomarker screening in bronchoalveolar lavage fluid
Poster

Proteomic non-small cell lung carcinoma biomarker screening in bronchoalveolar lavage fluid

Proteomic non-small cell lung carcinoma biomarker screening in bronchoalveolar lavage fluid
Poster

Proteomic non-small cell lung carcinoma biomarker screening in bronchoalveolar lavage fluid

Using a standardized method to acquire MALDI-TOF proteome profile spectra of bronchoalveolar lavage fluid (BALF), we have shown the upregulation of histatin 3 and calgranulin C in a small pilot cohort of NSCLC patients. This pilot study serves to demonstrate that it is feasible to screen a larger NSCLC patient cohort for BALF proteome level biomarkers in a clinical setting.
Advertisement